Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Salam AP, Duvignaud A, Jaspard M, Malvy D, Carroll M, Tarning J, Olliaro PL, Horby PW

Open source

DOI
10.1371/journal.pntd.0010289
Published
2022 Mar
Container
PLoS neglected tropical diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pntd.0010289,
  title = {Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.},
  author = {Salam AP and Duvignaud A and Jaspard M and Malvy D and Carroll M and Tarning J and Olliaro PL and Horby PW},
  year = {2022},
  journal = {PLoS neglected tropical diseases},
  doi = {10.1371/journal.pntd.0010289},
  url = {https://doi.org/10.1371/journal.pntd.0010289}
}

RIS

TY  - JOUR
TI  - Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.
AU  - Salam AP
AU  - Duvignaud A
AU  - Jaspard M
AU  - Malvy D
AU  - Carroll M
AU  - Tarning J
AU  - Olliaro PL
AU  - Horby PW
PY  - 2022
JO  - PLoS neglected tropical diseases
DO  - 10.1371/journal.pntd.0010289
UR  - https://doi.org/10.1371/journal.pntd.0010289
ER  - 

APA

AP, S., A, D., M, J., D, M., M, C., J, T., PL, O., & PW, H. (2022). Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.. PLoS neglected tropical diseases. https://doi.org/10.1371/journal.pntd.0010289

Source records